This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$34.22
US$ Class I Dist
NAV per share 22.09.2020
£601.5mAUM

AUM 28.08.2020

Holdings
70.69% Active Share
As at 28.08.2020